Partner Judy Waltz was quoted in a Bloomberg BNA article, “Drug, Device Markers Could Get Hit for Not Reporting Payments to Doctors,” covering the current and future states of the Open Payments program.
Waltz explained that Open Payments reporting “remains an administrative burden for drug and device manufacturers” but “payment reporting is becoming widespread throughout the health-care industry.” She also explained, as it relates to the future of the program, “the Trump administration has spoken about reducing regulatory burdens, and Open Payments could fit under that category.”
Waltz explained that Open Payments reporting “remains an administrative burden for drug and device manufacturers” but “payment reporting is becoming widespread throughout the health-care industry.” She also explained, as it relates to the future of the program, “the Trump administration has spoken about reducing regulatory burdens, and Open Payments could fit under that category.”
People
Related News
July 11, 2025
In the News
Foley Attorneys Assess Critical IP Considerations for Emerging Medical Device Companies
Foley & Lardner LLP attorneys Shabbi Khan, Nate Beaver, Austin Kim, and Jeff Simon authored the Med Device Online article, "Critical Considerations For IP & Patents For Emerging Medical Device Companies."
July 11, 2025
In the News
David Morris Featured for Arrival to Foley's Salt Lake City Office
Foley & Lardner LLP partner David Morris is highlighted across legal press for his recent arrival to the firm.
July 10, 2025
In the News
Ann Marie Uetz Comments on Automotive Supply Chain Approach to Evolving Tariff Environment
Foley & Lardner LLP partner Ann Marie Uetz shared perspective from the automotive supply chain amid the evolving trade environment in the Crain's Detroit article, "Ford, Stellantis tighten terms on suppliers as tariff costs add up."